# Periarticular Injection Versus Popliteal Block

> **NCT04575688** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Campbell Clinic** · enrollment: 100 (estimated)

## Conditions studied

- Foot Surgery
- Ankle Surgery

## Interventions

- **DRUG:** Exparel
- **DRUG:** Bupivicaine

## Key facts

- **NCT ID:** NCT04575688
- **Lead sponsor:** Campbell Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2021-07-13
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-02-28
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04575688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04575688, "Periarticular Injection Versus Popliteal Block". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04575688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*